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Abstract
Middle East Respiratory Syndrome-Coronavirus (MERS-CoV) is a novel coronavirus discovered in 2012 and is
responsible for acute respiratory syndrome in humans. Though not confirmed yet, multiple surveillance and
phylogenetic studies suggest a bat origin. The disease is heavily endemic in dromedary camel populations of East
Africa and the Middle East. It is unclear as to when the virus was introduced to dromedary camels, but data from
studies that investigated stored dromedary camel sera and geographical distribution of involved dromedary camel
populations suggested that the virus was present in dromedary camels several decades ago. Though bats and
alpacas can serve as potential reservoirs for MERS-CoV, dromedary camels seem to be the only animal host
responsible for the spill over human infections.
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Background
A novel coronavirus was isolated from a Saudi Arabian
patient with severe acute respiratory syndrome in June
2012 and the virus was later named Middle East Respira-
tory Syndrome - Coronavirus (MERS-CoV) [1]. Since
then, multiple outbreaks have been reported in or been
epidemiologically linked to the Arabian Peninsula. Up to
April 18, 2016, the Saudi authorities reported a total of
1386 cases of which 587 died [2]. With a high mortality
rate, lack of antiviral treatment, or preventive vaccine,
MERS-CoV remains a major public concern.
The first human coronavirus was cultivated in 1965 on
human ciliated embryonal tracheal cells [3]. Literature
about human coronaviruses was limited up until the
Severe Acute Respiratory Syndrome Coronavirus (SARS-
CoV) outbreak in 2002. The interest in coronaviruses
reemerged as a hot topic after MERS-CoV outbreaks. Cor-
onaviruses are enveloped, positive stranded RNA viruses
classified as a family within the Nidovirales order. They
have a crown appearance under the electron microscopy
due to the spike protein on the surface. The coronavirus
subfamily is classified into genera: alpha, beta, gama, and
delta. Human coronaviruses belong to alpha, and beta
coronaviruses [4].
MERS-CoV is a lineage C betacoronavirus with a geno-
type that is very closely related to bat coronaviruses from
the same lineage, such as BtCoV-HKU4 and BtCoV-
HKU5, though its evolutionary pathway is still unclear [5].
A limited number of coronaviruses is known to cause
human disease. Most of known coronaviruses infect and
circulate in animals, mainly bats. So when it comes to a
new novel coronavirus with limited geographic distribu-
tion, one would think of a zoonotic disease with animal
reservoir. This proved to be true with SARS and seems to
be the case with MERS-CoV. The origin of the virus and
the extent of its involvement in both human and animal
populations remain hot topics that are being explored
with phylogenicity and surveillance studies. In this review
we summarize the current evidence about MERS-CoV
origin and animal reservoir.* Correspondence: zmemish@yahoo.com
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MERS-CoV origin
It is believed that MERS-CoV, like many other corona-
viruses, originated in bats. This is based on the isolation of
other lineage C beta-coronaviruses that are very closely
related to MERS-CoV on phylogenetic analysis [6, 7].
A large screening study for beta-coronaviruses from
5030 bats’ fecal specimens was conducted between 2009
and 2011. In that study 4758 bats of ten different species
from Ghana, and 272 Pipistrellus bats from four European
countries were included [8]. Reverse Transcription Poly-
merase Chain Reaction (RT-PCR) was used to detect
coronavirus RNA. Of the ten bat species tested in Ghana,
only Nycteris gambiensis was found to carry 2c beta-
coronavirus. A round one fourth of the 185 Nycteris bats
tested positive; this accounted for 1 % of whole tested bat’s
population from Ghana. Of the Pipistrellus bat species
tested in Europe, 40 out of 272 (14.7 %) carried 2c beta-
coronavirus. Both 2c beta-coronaviruses isolated are genet-
ically very closely related to MERS-CoV. This relatedness
indicates that MERS-CoV likely originated from bats [8].
Though the study had a good sample size and screened
different geographical areas, none of those areas is known
for MERS-CoV infection in humans or domestic animals.
A report from South Africa identified a bat derived
coronavirus that has a very close phylogenetic relationship
to MERS-CoV [9]. The virus was isolated from a Neoromi-
cia cf. zuluensis bat sampled in 2011 [9]. In Saudi Arabia,
bat fecal samples collected in October of 2012 were tested
for MERS-CoV RNA. A product obtained by PCR amplifi-
cation of nucleic acid from a fecal pellet of a Taphozous
perforatus bat captured in Bisha showed 100 % nucleotide
match to the MERS-CoV cloned from an index case
patient living in the same area [10]. Though it was a single
190-nucleotide segment, it does give a clue that MERS-
CoV might be circulating in bats and that Taphozous
perforatus (Egyptian tomb bat) might be a source of
MERS-CoV.
A study of 821 bats captured in Egypt and Lebanon
between February 2013 and April 2015 did not detect
MERS-CoV in any of the bats sampled [11]. In that study
three species: Taphozous perforatus, Pipistrellus deserti,
and Rousettus aegyptiacus, were sampled from Egypt, and
four species: Rhinolophus hipposideros, Miniopterus schri-
bersii, Rhinolophus ferrumequinum, and Rousettus aegyp-
tiacus, were sampled from Lebanon [11]. Serum samples,
oral and rectal swabs were collected and tested from live
bats. Homogenized lung and liver material was tested
from 72 bats that died or were euthanized upon capture
[11]. One limitation of this study is that most of the bats
screened belong to one species, R. aegyptiacus (85 %), and
limited numbers of the other species were tested, espe-
cially T. perforatus (10 %).
To further investigate the role of bats as a potential
reservoir for MERS-CoV, an experimental study was
conducted on Jamaican fruit bat (Artibeus jamaicensis).
Ten bats were inoculated through intranasal and intra-
peritoneal routes with MERS-CoV [12]. All bats showed
evidence of infection as they shed the virus from their
respiratory and, to a lesser extent, intestinal tract, but
none of the bats showed clinical signs of disease [12].
The ability of MERS-CoV to replicate in bats without
clinical signs of disease indicates that they can serve as a
reservoir for MERS-CoV.
Thus, MERS-CoV, or its immediate ancestor, could
have likely originated in bats, and that bats can serve as
an ideal reservoir for MERS-CoV. It is difficult to proof
that bats are the direct source of human disease, based
on the available bats’ screening studies. In addition, here
is no clear direct contact between bats and humans,
especially in Saudi Arabia where most of the cases are
being diagnosed. A summary of important studies that
screened bats for beta-coronaviruses and MERS-CoV is
shown in Table 1.
Animal reservoir
Does MERS-CoV infect dromedary camels? Is there a role
for dromedary camels in human disease?
The first evidence to link MERS-CoV to dromedary
camels came from a serological study that investigated
different animals: dromedary camels, cattle, sheep, goats
and various other camelid species. MERS-CoV specific
antibodies were only found in dromedary camels [13].
Another evidence to link MERS-CoV to dromedaries
was found after two human cases of MERS-CoV infection,
diagnosed in October of 2013, and were linked to a farm
in Qatar [14]. In response, all the 14 dromedary camels on
that farm were tested with RT-PCR. Eleven dromedary
camels had positive nasal swabs for MERS-CoV. The
nucleotide sequence of an ORF1a fragment and a 4 · 2 kb
concatenated fragment of three dromedary camel samples
were very similar to the sequence from the two human
cases linked to that farm [14]. Another study from Saudi
Arabia described a 43 year old male who owned nine
dromedary camels and was in direct contact with them up
until he was diagnosed with MERS-CoV infection in
November 2013 [15]. Four of his dromedary camels were
sick before his symptoms started. Cell cultures from a
laboratory confirmed dromedary camel and the patient
grew genetically identical MERS-CoV viruses [15].
In addition to providing a virological confirmation of
MERS-CoV in dromedary camels, the last two studies
indicated a potential cross infection between dromedary
camels and humans and that the virus could be trans-
mitted from dromedary camels to humans through close
contact [14, 15]. A study that obtained the full genome
of MERS-CoV from a dromedary camel in Qatar showed
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that MERS-CoVs from dromedary camel and humans
are nearly identical [16].
A nation-wide cross-sectional serological study done in
Saudi Arabia between December 1st 2012 and December
1st 2013 in which serum samples from slightly over ten
thousand individuals, whom age and sex distribution
largely matched the general population, were tested for
MERS-CoV antibodies [17]. Positive results were con-
firmed in 15 individuals (0.15 %). Of note, seropositivity
was significantly higher in dromedary camel exposed indi-
viduals compared to the rest of the study population;
fifteen times higher in shepherds and twenty three times
higher in slaughterhouse workers [17]. This study does
not only support the theory of dromedary camel role in
human infection but also indicates a higher prevalence of
human seropositivity than expected, based on reported
cases from Saudi Arabia.
In another study, 498 serum samples obtained from
Qatar and Europe between 2013 and 2014 were tested for
MERS-CoV antibodies. 294 samples were obtained from
persons with occupational dromedary camel contact in
Qatar; the remaining 204 samples were obtained from
persons with no dromedary camel contacts from both
Qatar and Europe. Around 7 % of those with dromedary
camel contact tested positive for MERS-CoV antibodies,
while none of the samples from persons with no dromed-
ary camel contacts tested positive [18].
A case control study assessed differences in environ-
mental exposure between thirty laboratory confirmed pri-
mary MERS-CoV cases and 116 controls. The study was
conducted between March and November of 2014, and
the cases represented 8 out of 13 regions in Saudi Arabia.
The study concluded that direct dromedary camel expos-
ure within two weeks of symptoms onset is independently
associated with MERS-CoV infection [19].
So the evidence points to a close dromedary camel
contact as a major risk for human infection. In order to
better understand the ecology of MERS-CoV infection in
dromedary camels, three adult dromedary camels were
inoculated with a human isolate of MERS-CoV. Each
dromedary camel was inoculated though intratracheal,
intranasal and conjunctival routes. Transient, primarily
upper respiratory tract infection developed in each of the
three camels. Each dromedary camel shed large quantities
of virus from the upper respiratory tract, evidenced by the
presence of infectious viruses in nasal swab samples and,
to a lesser extent, in oral samples. No infectious virus or
viral RNA was detected in fecal, urine, serum or whole
blood samples [20]. After authentication, the virus was re-
covered from respiratory tissues and some lymph nodes
draining the respiratory system of one dromedary camel,
but not in any other organs. These findings were consist-
ent with the data from naturally infected dromedary
camels [6, 15, 21, 22]. Some studies reported the detection
Table 1 Summary of important studies that screened bats for beta-coronaviruses and MERS-CoV
Location Year Species Number Specimen Virus % Positive
Ghana [8] 2009–2011 Nycteris cf. gambiensis 185 Fecal 2c betacoronaviruses
(closely related to MERS-CoV)
24.9 %
Ghana [8] 2009–2011 9 different speciesa 4573 Fecal 0 %
Europe [8]
(Germany, Netherland,
Romania, Ukraine)
2009–2011 Pipistrellus kuhlii, P. nathusii,
P. pipistrellus, P. pygmaeus
272 Fecal 14.7 %
South Africa [9] 2011–2012 13 different speciesb 62 Fecal pellets bat related-
alphacoronaviruses
betacoronavirus
6.4 % 1.6
%
Saudi Arabia [10] 2012 Rhinopomahardwickii, R.microphyllum,
Taphozous perforatus, P. kuhlii,
Eptesicus bottae, Eidolon helvum, and
Rosettus aegyptiacus
96 Throat swab, serum,
urine, rectal swab or
fecal pellets
MERS-CoV 1 %
Saudi Arabia [10] 2013 R.hardwickii, T.perforates, P.kuhlii 14 Throat swabs, roost
feces
MERS-CoV 0 %
Egypt [11] 2013–2015 T. perforatus 82 Serum/rectal (alive) MERS-CoV 0 %
P. deserti 31
R. aegyptiacus 257
Lebanon [11] 2013–2015 R. hipposideros 4 Homogenized lung
and liver material
(if died or euthanized
upon capture)
0 %
Miniopterus schribersii 6
R. ferrumequinm 3
R. aegyptiacus 438
aColeura afra, Hipposiderosabae, H. cf. gigas, H. fuliginosus, H. jonesi, H. cf. ruber, Rhinolophus alcyone, R. landeri, Taphozous perforates
bChaerephonpumilus, Mops condylurus, Tadaridaaegyptiaca, H.caffer, Miniopterus natalensis, Nycteristhebaica, R.clivosus, R. darlingi, Neoromicia capensis,
N. nana, N. cf. zuluensis, Scotophilus viridis, Rousettus aegyptiacus
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of MERS-CoV virus from fecal specimen, though virus
detection rates were far lower than in nasal swab speci-
mens [22–24]. One study in particular reported detection
of MERS-CoV RNA in the milk of five out of seven
infected dromedary camels [23].
A vaccine expressing the MERS-CoV spike protein was
shown to confer mucosal immunity in dromedary camels
with evidence of serum neutralizing antibodies and signifi-
cant reduction in excreted infectious virus and viral RNA
transcripts in vaccinated animals [25].
Based on surveillance and epidemiological studies, it is
obvious that MERS-CoV infects dromedary camels, which
serve as a reservoir with spell over human infections
through close dromedary camel contacts [13–15, 17–19,
24]. The exact routes of transmission are not very well
understoodbut direct contacts with Dromedary camels or
the handling of surfaces or objects contaminated with
dromedary camels’ respiratory or fecal material may as
well pose a risk for infection.
What is the extent of MERS-CoV infection in dromedary
camels?
Multiple surveillance studies explored the extent of
MERS-CoV infection in dromedaries. Presence of specific
MERS-CoV antibodies in dromedary camels’ sera was
used as an indicator of previous exposure to the virus,
while the presence of MERS-CoV RNA material in nasal
secretions, usually identified through RT-PCR, indicated
current infection and active viral shedding.
Serum samples from 303 dromedary camels from
Saudi Arabia were screened in 2013 and found to have a
high seropositivity of 72 % to MERS-CoV [21].
All serum samples from 50 dromedary camels in
Oman were positive for MERS-CoV specific antibodies
[13]. Similar results were reached from a larger study
conducted in United Arab Emirates (UAE), where 500
dromedary camels’ sera screened in 2013 revealed 96 %
seropositivity [26].
In Africa, a study assessed the geographic distribution of
MERS-CoV among dromedaries by investigating serum
samples from Nigeria, Tunisia, and Ethiopia. In Nigeria,
serum samples collected between 2010 and 2011 from 358
adult dromedaries distributed over 4 provinces were
tested, and 94 % were positive for MERS-CoV antibodies.
In Tunisia, serum samples collected in 2009 and 2013
from 204 dromedaries distributed over 3 provinces were
tested and 48.5 % were positive for MERS-CoV. In
Ethiopia, 96.3 % of the serum samples collected between
2011 and 2013 from 188 dromedaries, distributed over 3
provinces, were positive for MERS-CoV antibodies [27].
Another study was conducted in Kano, Nigeria in January
2015. Nasal swabs and blood samples were collected from
dromedary camels shortly after slaughter at a slaughter-
house. The samples were tested for the presence of MERS-
CoV RNA using RT-PCR from nasal swabs. Sera were
tested for the presence of specific MERS-CoV antibodies.
Of the 132 dromedary camels screened with nasal swabs,
14 were found to carry the virus RNA (11 %). The overall
seropositivity was 95 % [28].
A random group of 105 dromedary camels presented
for slaughter in Qatar at two occasions in 2014 were
sampled for MERS-CoV. Nasal, oral, bronchial and rectal
swabs were tested for MERS-CoV. A high proportion
(59 %) of them was actively shedding the virus at the time
of slaughter. The percentage of positive samples was the
highest for nasal samples, followed by oral swabs, fecal
swabs, and bronchial swabs. Co-circulation of multiple
MERS-CoV variants, evidenced by five different sequence
types, demonstrates multiple virus introductions likely
related to the flow of new dromedary camels from differ-
ent origins [24].
Those findings indicate a widespread exposure to
MERS-CoV in the dromedary camel populations of
Africa and the Arabian Peninsula, to the extent that al-
most every adult dromedary camel got infected at some
point in life.
Do dromedary camels differ in their vulnerability to
MERS-CoV infection based on age?
Two hundred and three samples from live dromedary
camels in Saudi Arabia were collected in 2013 and found
to have a high seropositivity (72 %) to MERS-CoV [21].
Seropositivity was higher among adults dromedary camels
(two years and older) compared to juvenile dromedary
camels (less than two years of age), 95 % vs. 55 % respect-
ively [21]. Increasing seropositivity with age might be
related to increased likelihood of exposure and subsequent
infection over time.
In the same study, 202 dromedary camels’ nasal swabs
were tested for the presence of MERS-CoV RNA material
using RT-PCR; 25 % were positive. In other words, one
fourth of the tested dromedary camel population was
shedding the virus and was potentially infectious. Of those
shedding the virus 71 % were juvenile and 29 % were adult
dromedary camels older than two years [21]. The results
indicate that juvenile dromedary camels might be at
higher risk of contracting the virus. An explanation could
be that they are naive to the virus and lack neutralizing
antibodies.
When was the virus introduced to dromedary camels?
In an attempt to investigate the time frame of MERS-CoV
introduction to dromedary camel population, multiple
studies screened stored serum samples. 100 % seropositivity
was found in 151 dromedary camel serum samples
obtained in 2003 from UAE dromedary camels [26].
Archived serum samples, obtained from dromedary camels
in Saudi Arabia from1992 through 2010, were found to
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have a high seropositivity ranging from 72 % to 100 % [21].
189 stored dromedary camel serum samples from Egypt,
collected in 1997, and from Sudan and Somalia, collected
between 1983 and 1984, were tested, and 81 % were found
to have neutralizing antibodies to MERS-CoV [29].
Another study from Kenya showed similar results [30]. This
implies that MERS-CoV has been heavily endemic in both
the Middle East and East Africa’s dromedary camels for
decades.
In addition to evaluating MERS-CoV distribution and
the infection burden in dromedary camel populations,
screening different geographic areas might also help pre-
dict when MERS-CoV was introduced to dromedary
camels. Historically and up to the early twentieth century,
both dromedary and bactrian camels played a vital role in
carrying passengers and goods in North Africa, the Middle
East, and East Asia. For the same reason, they were
imported to Australia in the nineteenth century. After the
invention of automobile and the use of trains, use and
travel of dromedary and bactrian camels between coun-
tries was limited.
Serum samples collected from 105 dromedary camels
living in the Canary Islands, a Spanish archipelago
located just off the southern coast of Morocco, between
2012 and 2013 were tested, and 14 % were found to have
antibodies against MERS-CoV [13]. This indicates that a
small proportion of Canary Island dromedary camels were
exposed to the virus at some point in time. This low
percentage, compared to East Africa and the Arabian
Peninsula, might be related to the isolated nature of the
Canary Islands, as they are off the West African coast and
are governed by Spain. Those two factors might limit the
interaction of the island’s dromedary camels with those
from other parts of Africa. This theory was later sup-
ported by another study conducted in early 2015. In this
study, a representative sample of 170 dromedary camels
on the Canary Islands was investigated; only 4.1 % were
seropositive for MERS-CoV. All the seropositive dromed-
ary camels were imported from Africa 20 or more years
prior. This led to the conclusion that active infection and
shedding didn’t take place on the Canary Islands [31].
In an attempt to screen feral camels in Australia, 307
dromedary camels’ sera from two different locations were
sampled between December 2013 and June 2014. All
tested negative for specific MERS-CoV antibodies [32].
In Kazakhstan 550 camels’ sera: 455 dormeday and 95
bactrian, camels with two humps (Camelus bactrianus),
were screened for MERS-CoV between February and
March 2015, and all tested negative [33]. Another sur-
veillance study was conducted in southern Mongolia in
November of 2014. In that study, 210 bactrian camels
from 12 herds were screened. All samples tested nega-
tive, and the study concluded that MERS-CoV was not
present in bactrian camels of the screened areas [34].
A serological and virological surveillance study of ten
bactrian camel herds in three areas of the West of Inner
Mongolia Autonomous Region (IMAR) was conducted in
2015. One hundred and ninety Bactrian camels were sam-
pled; nasal swab and serum samples were collected from
each Bactrian camel. All samples turned negative and the
study concluded that there was no MERS-CoV circulating
among Bactrian camels in the West IMAR [35].
Based on the above studies, it seems that MERS-CoV
infection is limited to dromedary camel populations in
Africa and the Middle East. This may indicate that drom-
edary camel infection could have been introduced at a
point in time when the dromedary camel caravans be-
tween Asia, Middle East, and Africa were no longer active.
Are there other domestic animal reservoirs for
MERS-CoV?
In an attempt to investigate the possibility of other reser-
voirs, multiple domestic animal populations were screened.
In a serological study, conducted in Saudi Arabia between
2010 and 2013, sera from 100 sheep, 45 goats, 50 cattle,
and 240 chickens representing different geographical areas
within the country were collected. All samples tested nega-
tive for MERS-CoV [36]. In another study, serum samples
from 36 goats and 102 sheep from central Saudi Arabia
tested negative for MERS-CoV antibodies as well [21]. In
2013 a similar study was conducted in Jordan. None of the
150 goats, 126 sheep and 91 cows tested was found positive
for MERS-CoV antibodies [37]. Sera from European sheep,
goats, and cattle had no evidence of MERS-CoV antibodies
as well [13].
Equids were also screened for MERS-CoV antibodies.
192 adult horse samples from UAE and 861 samples
from Spain (697 horses, 82 donkeys, and 82 mules) were
screened. All were seronegative for MERS-CoV [38].
Dromedary camels seemed to be the only domestic ani-
mal reservoir for MERS-CoV up until a recent study con-
ducted in Qatar in April of 2015 investigated the MERS-
CoV infection status of 15 healthy alpacas (Vicugna pacos)
in a herd of 20 that shared a barn complex with dromed-
aries. All tested alpacas were seropositive to MERS-CoV
(100 %). Of note, MERS-CoV is endemic in Qatar’s drom-
edaries, and nine out of ten dromedary camels that shared
the same barn complex were seropositive for MERS-CoV
[39]. This indicates the susceptibility of alpacas for natural
MERS-CoV infection and the potential for a new MERS-
CoV animal reservoir. Of note, a previous study found no
evidence for MERS-CoV infection in alpacas from regions
where MERS-CoV is not endemic [13].
In another study 3 alpacas were experimentally infected
through intranasal insulation of MERS-CoV viruses. All
got infected and shed the virus; they also transmitted the
infection to two out of three other alpacas that shared the
same room. Similar to dromedary camels, infected alpacas
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didn’t develop fever, but unlike dromedary camels, none
of the alpacas had any observable nasal discharge over the
course of infection. All infected animals were able to
mount neutralizing antibodies to MERS-CoV [40].
Those studies indicate that alpacas, similar to dromed-
ary camels, can be infected and potentially serve as a
reservoir.
Conclusion
Our experience with MERS-CoV is of zoonotic nature,
transmitted to humans from infected dromedary camels.
The origin of MERS-CoV viral infection is not very well
understood. It could have originated in bats and transmit-
ted to dromedary camels at some unknown time in the
past.
The virus seems to be well maintained in dromedaries,
which serve as a reservoir with a spill over human infec-
tions. Sporadic human cases in areas where MERS-CoV is
endemic in dromedary camels are likely to continue to
happen.
The awareness of the disease and the easy access to a
more developed health care system could explain the
higher incidence of MERS-CoV diagnosis in Saudi Arabia
compared to other countries in Africa where the disease is
likely to be overlooked.
Larger scale serological screening of human populations
in areas where MERS-CoV is endemic in dromedary
camels should be considered. More extensive screening of
bats in Saudi Arabia and East Africa, especially the
Egyptian tomb bat, needs to be considered. Screening
dromedary camel populations in Africa (Sahara desert and
surrounding areas), and East Asia (Pakistan, Afghanistan,
and Iran) will help better delineate the geographical distri-
bution of dromedaries involvement.
Experimental MERS-CoV inoculation of other domestic
animals will help define predisposed groups and should be
considered so as to guide screening efforts for other
potential reservoirs.
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